$11.64 0.00%
RENE Stock Price vs. AI Score
Data gathered: December 12

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Cartesian Growth Corporation

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities.


Cartesian Growth Corporation
Price $11.64
Target Price Sign up
Volume 4,630
Market Cap $151M
Year Range $11.13 - $11.67
Dividend Yield 0%
PE Ratio 26.45
Analyst Rating 0% buy
Industry SPAC

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '240002.9M-220,0000.135
Q2 '24100,0000100,0002.1M-200,0000.098
Q1 '2401.2M-1.3M2.5M-220,0000.117
Q4 '230200,000-1.1M2.1M-1.3M0.090
Q3 '230220,00001.9M-210,0000.065

What is the Market Cap of Cartesian Growth Corporation?

The Market Cap of Cartesian Growth Corporation is $151M.

What is Cartesian Growth Corporation's PE Ratio?

As of today, Cartesian Growth Corporation's PE (Price to Earnings) ratio is 26.45.

What is the current stock price of Cartesian Growth Corporation?

Currently, the price of one share of Cartesian Growth Corporation stock is $11.64.

How can I analyze the RENE stock price chart for investment decisions?

The RENE stock price chart above provides a comprehensive visual representation of Cartesian Growth Corporation's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cartesian Growth Corporation shares. Our platform offers an up-to-date RENE stock price chart, along with technical data analysis and alternative data insights.

Does RENE offer dividends to its shareholders?

As of our latest update, Cartesian Growth Corporation (RENE) does not offer dividends to its shareholders. Investors interested in Cartesian Growth Corporation should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cartesian Growth Corporation?

Some of the similar stocks of Cartesian Growth Corporation are Nabors Energy Transition, Investcorp Europe Acquisition, Screaming Eagle Acquisition, Ares Acquisition, and Nabors Energy Transition.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.